| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,781 |
34,778 |
$2.30M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
13,042 |
12,468 |
$1.12M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,099 |
4,022 |
$914K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,489 |
2,436 |
$257K |
| 76801 |
|
2,571 |
2,526 |
$238K |
| 76813 |
|
2,324 |
2,279 |
$151K |
| 59025 |
Fetal non-stress test |
6,195 |
3,788 |
$129K |
| 0502F |
|
11,649 |
9,321 |
$113K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,383 |
2,558 |
$113K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,708 |
1,699 |
$82K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
249 |
248 |
$81K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,101 |
1,052 |
$71K |
| 76818 |
|
1,282 |
762 |
$69K |
| 99215 |
Prolong outpt/office vis |
399 |
247 |
$31K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
76 |
76 |
$25K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
12 |
12 |
$17K |
| 99429 |
|
93 |
91 |
$12K |
| 90715 |
|
570 |
565 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
104 |
98 |
$5K |
| 76820 |
|
151 |
92 |
$4K |
| 81513 |
|
256 |
219 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
887 |
712 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
61 |
61 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
973 |
782 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
684 |
551 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
95 |
93 |
$2K |
| 87481 |
|
225 |
186 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
214 |
178 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27 |
27 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
96 |
88 |
$1K |
| 93976 |
|
14 |
12 |
$961.39 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
207 |
182 |
$696.14 |
| 81025 |
|
143 |
139 |
$624.88 |
| 90674 |
|
22 |
22 |
$403.78 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
377 |
336 |
$309.13 |
| 36415 |
Collection of venous blood by venipuncture |
115 |
104 |
$289.23 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
1,096 |
931 |
$161.92 |
| 86780 |
|
28 |
27 |
$140.81 |
| 86803 |
|
27 |
24 |
$137.87 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$123.74 |
| 99459 |
|
12 |
12 |
$120.34 |
| 0500F |
|
12 |
12 |
$100.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$66.29 |
| 87340 |
|
12 |
12 |
$58.92 |
| 81002 |
|
15 |
12 |
$4.39 |